News

In collaboration with the Biden Cancer Initiative, today the American Society of Hematology (ASH) shared an update on its commitment to develop a research-focused data registry on multiple myeloma.
Read more on American Society of Hematology »
People with deep-vein thrombosis (DVT) can substantially cut their risk of potentially debilitating complications by starting adequate compression therapy during the acute phase of DVT therapy, suggests a study published today in the journal Blood.
Read more on American Society of Hematology »
The American Society of Hematology today joined 24 organizations to publish a report card on the state of sickle cell disease in 2018.
Read more on American Society of Hematology »
A new review looks at the major factors affecting bone health in mematologic stem cell transplant recipients, and provides expert guidance for the monitoring, evaluation and treatment of bone loss in these patients.
Read more on Science Daily »
The National Institutes of Health today announced the launch of the Cure Sickle Cell Initiative, a collaborative research effort to accelerate the study of curative gene therapies for sickle cell disease.
Read more on American Society of Hematology »
Omacetaxine (to block protein synthesis) with venetoclax (to block oxidative phosphorylation), was highly effective against CD123+ leukemia stem cells.
Read more on Science Daily »
Investigators have unraveled the origins and identified mutations associated with a perplexing form of acute leukemia. The landmark study appears today as an advance online publication in the journal Nature and lays the foundation for more effective treatment of patients…
Read more on Science Daily »
Researchers have made important discoveries that could lead to better treatment for a rare blood cancer in children that has features of both leukemia and lymphoma.
Read more on Science Daily »
ASH is launching a sickle cell disease (SCD) clinical trials network in order to accelerate the development of new therapies for a patient community that has very few treatments and curative options.
Read more on American Society of Hematology »
The DNA-based test paves the way for precision medicine by giving leukemia patients personal disease prognosis based on mutation frequency in their cancer cells.
Read more on Science Daily »
A study suggests that leukemia cells change in unique ways in response to chemotherapy allowing them to masquerade for a short time so they are able to start disease regeneration.
Read more on Science Daily »
Adult humans have ten times more blood-creating stem cells in their bone marrow than previously thought, ranging between 50,000 and 200,000 stem cells. Researchers developed a new approach for studying stem cells, based on methods used in ecology.
Read more on Science Daily »
The American Society of Hematology has selected eight early-career hematology researchers from across the globe as the first recipients of the new ASH Global Research Award, an award established for international members of the Society.
Read more on American Society of Hematology »
Acute myeloid leukemia is one of the most aggressive cancers. Now, scientists have developed a new biological drug with a cure rate of 50 percent for lab mice with acute leukemia.
Read more on Science Daily »
Study describes progress toward 'humanized' mouse: Adding second stem-cell type improves model, allows better testing of cancer immunotherapies.
Read more on Science Daily »
Scientists may be on the road to solving the mystery of a group of mostly incurable blood diseases called myelodysplastic syndromes (MDS), which cause people to have immature, malfunctioning bone marrow cells that fuel a diverse set of health problems…
Read more on Science Daily »
Epstein-Barr Virus (EBV) doesn't directly cause cancer, but infection with this common herpes virus brings an increased risk of some cancers, including fast-growing lymphomas. This week in mSphere, researchers report on a new drug that works by targeting EBV-positive tumors.
Read more on Science Daily »